{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:03:30Z","timestamp":1784783010821,"version":"3.55.0"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Precis<\/jats:title>\n                    <jats:p>Approximately one-quarter of lacrimal gland masses present with imaging findings not consistent with standard teaching for benign vs. malignant; it is prudent to do gross total resection in such cases if eye-sparing surgery is possible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Epithelial lacrimal gland tumors are rare. The initial surgical decision to do an incisional biopsy vs. gross total resection depends largely on the radiologic characteristics of the lacrimal gland mass. Occasionally, the reported radiologic features attributed to benign vs. malignant lacrimal gland tumors do not hold. In this report, we will focus on these atypical presentations to help the orbital surgeon with better surgical planning.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Epithelial lacrimal gland tumors diagnosed in 101 consecutive patients (59 adenoid cystic carcinomas, 24 other carcinomas, and 18 pleomorphic adenomas) and treated by the primary author were included. The clinical and radiologic records were retrospectively reviewed. The clinical parameters analyzed included age, gender, histologic type, and surgical treatment. The radiologic data analyzed included radiologic characteristics of the lacrimal gland mass on the initial magnetic resonance imaging (MRI) and\/or computed tomography (CT) at presentation. Cases that did not follow the \u201cstandard\u201d imaging characteristics of carcinoma or pleomorphic adenoma were further analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, two possible atypical radiologic patterns were identified: (1) 11 of 59 (19%) cases of adenoid cystic carcinoma and 5 of 24 (21%) cases of other carcinomas were identified where the lesion was round and well-circumscribed, lacked a posterior extension or other aggressive features, and could not be distinguished from pleomorphic adenoma but after surgical resection were found to be adenoid cystic carcinoma or other types of lacrimal gland carcinoma; (2) 5 of 18 (28%) cases of pleomorphic adenoma presented with large multilobular masses and could not be distinguished from a carcinoma but in fact were found to be of benign nature on histologic evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggest some overlap in radiologic features between pleomorphic adenomas and lacrimal gland carcinomas. Given the risk of multifocal benign or malignant recurrence of pleomorphic adenomas if excised incompletely, it seems prudent to err on the side of gross total resection for most well-circumscribed lesions of the lacrimal gland that lack aggressive radiologic features. Some of these well-circumscribed lesions will end up being adenoid cystic carcinoma or other types of lacrimal gland carcinomas upon pathologic evaluation of the surgical specimen and may require additional treatments.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1852743","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:28:18Z","timestamp":1784780898000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Atypical imaging characteristics in patients with epithelial tumors of lacrimal gland and impact on initial surgical planning"],"prefix":"10.3389","volume":"16","author":[{"given":"Bita","family":"Esmaeli","sequence":"first","affiliation":[{"name":"Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center","place":["Houston, TX, United States"]},{"name":"Oncologic Ophthalmic Plastic & Orbital Surgery, Mann Eye Institute","place":["Houston, TX, United States"]},{"name":"Department of Clinical Sciences, University of Houston Fertitta Family College of Medicine","place":["Houston, TX, United States"]},{"name":"Department of Ophthalmology, Houston Methodist Hospital\/Weill Cornell Medical College","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Lu","sequence":"additional","affiliation":[{"name":"Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Ketonen","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, The University of Texas MD Anderson Cancer Center","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Matthew","family":"Debnam","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, The University of Texas MD Anderson Cancer Center","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0033-8389(05)70089-0","article-title":"Lacrimal gland tumors and simulating lesions: Clinicopathologic and MR imaging features","volume":"37","author":"Mafee","year":"1999","journal-title":"Radiol Clin North Am"},{"key":"B2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1755-3768.2012.02402.x","article-title":"Epithelial tumors of the lacrimal gland: a clinical, histopathological, surgical and oncological survey","volume":"91","author":"Holstein","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.03.004","article-title":"The \u201cWedge Sign\u201d: An imaging sign of aggressive lacrimal gland disease","volume":"124","author":"Lorenzano","year":"2017","journal-title":"Ophthalmology"},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-62426-2_18","article-title":"Pleomorphic adenoma of the lacrimal gland","volume-title":"Atlas of Orbital Imaging","author":"Sagiv","year":"2022"},{"key":"B5","doi-asserted-by":"publisher","first-page":"101600","DOI":"10.1016\/j.ajoc.2022.101600","article-title":"Multifocal recurrence of pleomorphic adenoma of the lacrimal gland","volume":"27","author":"Zhao","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-62426-2_96","article-title":"Recurrent pleomorphic adenoma of the lacrimal gland (RLGPA)","volume-title":"Atlas of Orbital Imaging","author":"Sagiv","year":"2022"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-62426-2_19","article-title":"Lacrimal gland carcinoma: primary","volume-title":"Atlas of Orbital Imaging","author":"Sagiv","year":"2022"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/01.iop.0000232164.00208.b4","article-title":"Surgical management of locally advanced adenoid cystic carcinoma of the lacrimal gland","volume":"22","author":"Esmaeli","year":"2006","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/iop.0000000000002967","article-title":"Successful neoadjuvant treatment using trastuzumab emtansine (Kadcyla) for locally advanced and metastatic lacrimal gland adenocarcinoma","volume":"41","author":"Kakouri","year":"2025","journal-title":"Ophthalmic Plast Rconstr Surg"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-316142","article-title":"Prognostic factors for local recurrence and survival and impact of local treatments on survival in lacrimal gland carcinoma","volume":"105","author":"Ford","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2023.10.019","article-title":"Diagnostic value of dynamic contrast enhancement combined with conventional MRI in differentiating benign and Malignant lacrimal gland epithelial tumors","volume":"79","author":"Jian","year":"2024","journal-title":"Clin Radiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2025-327745","article-title":"Disease-specific and overall survival for patients with lacrimal gland adenoid cystic carcinoma in recent decades","volume":"110","author":"Esmaeli","year":"2025","journal-title":"Br J Ophthalmol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1097\/iop.0000000000000877","article-title":"Long-term outcomes of eye-sparing surgery for adenoid cystic carcinoma of lacrimal gland","volume":"34","author":"Han","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ajo.2018.12.013","article-title":"Long-term outcomes of globe-preserving surgery with proton beam radiation for adenoid cystic carcinoma of the lacrimal gland","volume":"195","author":"Wolkow","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26073","article-title":"Outcomes after eye-sparing surgery vs. orbital exenteration in patients with lacrimal gland carcinoma","volume":"42","author":"Bonavolont\u00e0","year":"2020","journal-title":"Head Neck"},{"key":"B16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/eye.2008.16","article-title":"Pleomorphic adenoma of the lacrimal gland: is there a role for biopsy","volume":"23","author":"Lai","year":"2009","journal-title":"Eye (Lond)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2022.03.027","article-title":"Neoadjuvant intra-arterial cytoreductive chemotherapy for lacrimal gland adenoid cystic carcinoma: a long-term follow-up study of a trimodal strategy","volume":"240","author":"Tse","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/oncolo\/oyad346","article-title":"Neoadjuvant intra-arterial cytoreductive chemotherapy improves outcomes in lacrimal gland adenoid cystic carcinoma","volume":"29","author":"Costa","year":"2024","journal-title":"Oncologist"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1852743\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T04:28:19Z","timestamp":1784780899000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1852743\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":18,"alternative-id":["10.3389\/fonc.2026.1852743"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1852743","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"article-number":"1852743"}}